Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 303, pseudogene (RN7SL303P)

Target
RN7SL303P
Molecular classification
Other
01

Overview

RNA, 7SL, cytoplasmic 303, pseudogene (RN7SL303P), is classified as a **pseudogene** derived from the 7SL RNA sequence. The 7SL RNA is a functional non-coding RNA that is a component of the signal recognition particle (SRP), which plays an essential cellular role in co-translational targeting of proteins to the endoplasmic reticulum[6]. However, RN7SL303P itself is **not a functional gene**; it represents a truncated, non-functional copy (pseudogene) arising from reverse transcription and integration events[3][4][5][7]. The vast majority of 7SL RNA-like sequences present in the human genome are pseudogenes such as RN7SL303P, which do not produce functional RNA or protein products and are not involved in normal biology or disease mechanisms[3][7]. RN7SL303P is not recognized as a receptor, enzyme, transporter, or other therapeutic target, nor is it a biomarker or associated with any disease pathway or drug interaction[1][4]. Its only significance is as a genomic fossil indicative of the evolutionary history of retrotransposition events involving the 7SL RNA gene family[3][5][7]. Notes: - This entry is **not an actionable or therapeutically relevant target** by any standard classification. - The gene symbol is correctly specified, but it should not be confused with the functional RN7SL1 or other active signal recognition particle RNA genes. - No known drugs, mechanisms of action, disease roles, or biomarkers are associated with this pseudogene. - If you are searching for a therapeutic target, this entry is incorrect; it does not represent a biologically functional molecule[4].

Other names
RN7SL303P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 303, pseudogene (RN7SL303P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 303, pseudogene (RN7SL303P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call